Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Before taking selumetinib, tell your doctor about all your medical conditions, including: heart problems, eye problems, and liver problems.What are the important precautions when u···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：230
Selumetinib is used to treat type 1 neurofibromatosis (NF1) in pediatric patients aged 2 years and older who have symptomatic, inoperable plexiform neurofibromas (an orphan drug de···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：167
Selumetinib is used to treat patients with neurofibromatosis type 1 (NF1) with plexiform neurofibromas that cannot be surgically removed.What side effects may Selumetinib cause?Sel···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：173
The dosage of this medicine is individualized. Please follow the doctor’s instructions or the information on the medicine label. The following is only the average adult dosage. Do ···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：245
Sparsentan is indicated for slowing the progression of renal function decline in patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease deterior···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：252
The dosage of sparsentan is individualized; please use it in accordance with your doctor’s instructions or the information on the drug label.What are the daily precautions for spar···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：217
Sparsentan is indicated for slowing the decline in renal function in adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.What Pre···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：194
Belzutifan produced by Lucius Pharmaceuticals is a bioequivalent generic drug with the same mechanism of action as the marketed drug. It is indicated for the treatment of diseases ···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：160
The version of belzutifan produced by Lucius Pharmaceuticals is a more cost-effective generic drug, designed to provide renal cell carcinoma patients with the same active ingredien···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：183
Belzutifan is an oral targeted drug of the hypoxia-inducible factor-2α (HIF-2α) inhibitor class, mainly indicated for the treatment of various tumors associated with von Hippel-Lin···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：203
Belzutifan is a hypoxia-inducible factor (HIF) inhibitor. It exerts its effect by blocking a protein known as HIF-2α.Is Belzutifan associated with severe side effects?The severe si···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：203
Doctors should conduct regular follow-ups to evaluate the efficacy of the medication, and adverse reactions may need to be monitored through blood and urine tests.Precautions for U···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：126
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
